Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Immunology Publisher



Keshavarzfathi M1, 2 ; Keshavarzfathi M1, 2 ; Rezaei N2, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Encyclopedia of Infection and Immunity Published:2022


Abstract

Immune evasion is one of the hallmarks of cancer and the dynamic interaction of the immune system and tumor is of great importance for understanding of cancer pathogenesis. The investigation of cancer immunology has begun from the early years of the 20th century and has been advanced in recent decades to the extent that many immune-based interventions have been applied for cancer treatment and resulted in improvement of patients’ survival. There are a lot yet to be undertaken in this field; therefore, a profound understanding of the roles of the immune system in cancer eradication and progression can assist the researchers and clinicians to design and apply more effective and safer modalities for cancer treatment or prevention. Herein, we will provide a bench to bedside discussion on cancer immunology and immunotherapy. © 2022 Elsevier Inc. All rights reserved.
Related Docs
View other Related Docs
1. Tumor Immunology, Clinical Immunology (2022)
2. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
3. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
4. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
5. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
6. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
7. The Pro-Tumorigenic Responses in Metastatic Niches: An Immunological Perspective, Clinical and Translational Oncology (2023)
8. The Immunobiology of Myeloid-Derived Suppressor Cells in Cancer, Tumor Biology (2016)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (74)
Jamshid Hadjati (8)
Other Related Docs
9. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
10. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
11. Tumor Immunotherapies by Immune Checkpoint Inhibitors (Icis); the Pros and Cons, Cell Communication and Signaling (2022)
12. The Role of Myeloid-Derived Suppressor Cells in Lung Cancer and Targeted Immunotherapies, Expert Review of Anticancer Therapy (2022)
13. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
14. The Role of T Helper 17 and Regulatory T Cells in Tumor Microenvironment, Immunopharmacology and Immunotoxicology (2019)
15. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)
16. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
17. Immune Checkpoint Inhibitor (Ici) Therapy in Central Nervous System Cancers: State-Of-The-Art and Future Outlook, International Immunopharmacology (2025)
18. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
19. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)
20. Chemotherapy: A Double-Edged Sword in Cancer Treatment, Cancer Immunology# Immunotherapy (2022)
21. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
22. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
23. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
24. Myeloid-Derived Suppressor Cells in B Cell Malignancies, Tumor Biology (2015)
25. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond, Archivum Immunologiae et Therapiae Experimentalis (2019)
26. An Update to Experimental and Clinical Aspects of Tumor-Associated Macrophages in Cancer Development: Hopes and Pitfalls, Clinical and Experimental Medicine (2024)
27. Targeting Hypoxia and Hypoxia-Inducible Factor-1 in the Tumor Microenvironment for Optimal Cancer Immunotherapy, Journal of Cellular Physiology (2022)
28. Biomarkers for Immune Checkpoint Inhibitors, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
29. The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
30. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
31. Immune Checkpoint Inhibition for Pancreatic Cancer, Acta Medica Iranica (2023)
32. The Immune System, Clinical Immunology (2022)
33. Controversial Role of Γδ T Cells in Pancreatic Cancer, International Immunopharmacology (2022)
34. A Comprehensive Review About the Utilization of Immune Checkpoint Inhibitors and Combination Therapy in Hepatocellular Carcinoma: An Updated Review, Cancer Cell International (2022)
35. Recent Advances in Immune Checkpoint Therapy in Non-Small Cell Lung Cancer and Opportunities for Nanoparticle-Based Therapy, European Journal of Pharmacology (2021)
36. Autoimmune Diseases, Clinical Immunology (2022)
37. Immune Checkpoint Inhibitors and Cardiotoxicity: Possible Mechanisms, Manifestations, Diagnosis and Management, Expert Review of Anticancer Therapy (2021)
38. Role of the Wnt and Gtpase Pathways in Breast Cancer Tumorigenesis and Treatment, Cytokine and Growth Factor Reviews (2022)
39. Immune Regulatory Network in Successful Pregnancy and Reproductive Failures, Biomedicine and Pharmacotherapy (2017)
40. Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications, Cellular Oncology (2019)
41. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
42. Immune Checkpoint Inhibitors in Cancer Therapy, Current Oncology (2022)
43. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
44. Chimeric Antigen Receptor -T Cell Therapy: Applications and Challenges in Treatment of Allergy and Asthma, Biomedicine and Pharmacotherapy (2020)
45. Immunotherapy in Bladder and Renal Cancers, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
46. The Promising Role of Monoclonal Antibodies for Gastric Cancer Treatment, Immunotherapy (2019)
47. Dendritic Cells Currently Under the Spotlight; Classification and Subset Based Upon New Markers, Immunological Investigations (2021)
48. Potent Anti-Tumor Immune Response and Tumor Growth Inhibition Induced by Her2 Subdomain Fusion Protein in a Mouse Tumor Model, Journal of Cancer Research and Clinical Oncology (2023)
49. Clinical and Diagnostic Potential of Regulatory T Cell Markers: From Bench to Bedside, Transplant Immunology (2022)
50. Immune Checkpoint Blockade in Melanoma: Advantages, Shortcomings and Emerging Roles of the Nanoparticles, International Immunopharmacology (2022)